Acme United Corporation (ACU) Stock Competitors & Peer Comparison
See (ACU) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACU | $51.88 | +11.28% | 174.9M | 19.78 | $2.32 | +1.40% |
| PG | $146.21 | -1.28% | 347.3B | 21.49 | $6.94 | +2.85% |
| UL | $60.24 | -0.90% | 133.2B | 20.34 | $3.04 | +3.68% |
| CL | $89.66 | -0.93% | 73.3B | 24.43 | $3.75 | +2.29% |
| KVUE | $18.82 | -1.03% | 36.7B | 16.49 | $1.16 | +4.34% |
| KMB | $106.81 | -1.15% | 36.1B | 14.38 | $7.57 | +4.66% |
| EL | $79.55 | -3.43% | 29.9B | 37.39 | $2.21 | +1.69% |
| CHD | $95.59 | -0.17% | 23B | 27.28 | $3.56 | +1.25% |
| CLX | $93.83 | -1.94% | 11.6B | 14.19 | $6.75 | +5.18% |
| REYN | $25.19 | -2.50% | 5.5B | 15.46 | $1.68 | +3.54% |
Stock Comparison
ACU vs PG Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, PG has a market cap of 347.3B. Regarding current trading prices, ACU is priced at $51.88, while PG trades at $146.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas PG's P/E ratio is 21.49. In terms of profitability, ACU's ROE is +0.08%, compared to PG's ROE of +0.31%. Regarding short-term risk, ACU is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check PG's competition here
ACU vs UL Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, UL has a market cap of 133.2B. Regarding current trading prices, ACU is priced at $51.88, while UL trades at $60.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas UL's P/E ratio is 20.34. In terms of profitability, ACU's ROE is +0.08%, compared to UL's ROE of +0.36%. Regarding short-term risk, ACU is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check UL's competition here
ACU vs CL Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, CL has a market cap of 73.3B. Regarding current trading prices, ACU is priced at $51.88, while CL trades at $89.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas CL's P/E ratio is 24.43. In terms of profitability, ACU's ROE is +0.08%, compared to CL's ROE of +4.75%. Regarding short-term risk, ACU is more volatile compared to CL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check CL's competition here
ACU vs KVUE Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, KVUE has a market cap of 36.7B. Regarding current trading prices, ACU is priced at $51.88, while KVUE trades at $18.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas KVUE's P/E ratio is 16.49. In terms of profitability, ACU's ROE is +0.08%, compared to KVUE's ROE of +0.15%. Regarding short-term risk, ACU is more volatile compared to KVUE. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check KVUE's competition here
ACU vs KMB Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, KMB has a market cap of 36.1B. Regarding current trading prices, ACU is priced at $51.88, while KMB trades at $106.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas KMB's P/E ratio is 14.38. In terms of profitability, ACU's ROE is +0.08%, compared to KMB's ROE of +1.44%. Regarding short-term risk, ACU is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check KMB's competition here
ACU vs EL Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, EL has a market cap of 29.9B. Regarding current trading prices, ACU is priced at $51.88, while EL trades at $79.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas EL's P/E ratio is 37.39. In terms of profitability, ACU's ROE is +0.08%, compared to EL's ROE of -0.06%. Regarding short-term risk, ACU is more volatile compared to EL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check EL's competition here
ACU vs CHD Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, CHD has a market cap of 23B. Regarding current trading prices, ACU is priced at $51.88, while CHD trades at $95.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas CHD's P/E ratio is 27.28. In terms of profitability, ACU's ROE is +0.08%, compared to CHD's ROE of +0.17%. Regarding short-term risk, ACU is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check CHD's competition here
ACU vs CLX Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, CLX has a market cap of 11.6B. Regarding current trading prices, ACU is priced at $51.88, while CLX trades at $93.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas CLX's P/E ratio is 14.19. In terms of profitability, ACU's ROE is +0.08%, compared to CLX's ROE of +28.26%. Regarding short-term risk, ACU is more volatile compared to CLX. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check CLX's competition here
ACU vs REYN Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, REYN has a market cap of 5.5B. Regarding current trading prices, ACU is priced at $51.88, while REYN trades at $25.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas REYN's P/E ratio is 15.46. In terms of profitability, ACU's ROE is +0.08%, compared to REYN's ROE of +0.15%. Regarding short-term risk, ACU is more volatile compared to REYN. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check REYN's competition here
ACU vs ELF Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, ELF has a market cap of 4.7B. Regarding current trading prices, ACU is priced at $51.88, while ELF trades at $76.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas ELF's P/E ratio is 25.23. In terms of profitability, ACU's ROE is +0.08%, compared to ELF's ROE of +0.02%. Regarding short-term risk, ACU is more volatile compared to ELF. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check ELF's competition here
ACU vs NTCO Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, ACU is priced at $51.88, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas NTCO's P/E ratio is -11.37. In terms of profitability, ACU's ROE is +0.08%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, ACU is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check NTCO's competition here
ACU vs IPAR Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, IPAR has a market cap of 3.9B. Regarding current trading prices, ACU is priced at $51.88, while IPAR trades at $119.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas IPAR's P/E ratio is 23.19. In terms of profitability, ACU's ROE is +0.08%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, ACU is more volatile compared to IPAR. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check IPAR's competition here
ACU vs COTY Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, COTY has a market cap of 2.4B. Regarding current trading prices, ACU is priced at $51.88, while COTY trades at $2.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas COTY's P/E ratio is 15.19. In terms of profitability, ACU's ROE is +0.08%, compared to COTY's ROE of -0.15%. Regarding short-term risk, ACU is more volatile compared to COTY. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check COTY's competition here
ACU vs NWL Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, NWL has a market cap of 2.2B. Regarding current trading prices, ACU is priced at $51.88, while NWL trades at $5.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas NWL's P/E ratio is 9.65. In terms of profitability, ACU's ROE is +0.08%, compared to NWL's ROE of -0.11%. Regarding short-term risk, ACU is more volatile compared to NWL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check NWL's competition here
ACU vs SPB Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, SPB has a market cap of 2.1B. Regarding current trading prices, ACU is priced at $51.88, while SPB trades at $86.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas SPB's P/E ratio is 13.68. In terms of profitability, ACU's ROE is +0.08%, compared to SPB's ROE of +0.07%. Regarding short-term risk, ACU is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SPB's competition here
ACU vs EPC Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, EPC has a market cap of 1.3B. Regarding current trading prices, ACU is priced at $51.88, while EPC trades at $26.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas EPC's P/E ratio is 13.54. In terms of profitability, ACU's ROE is +0.08%, compared to EPC's ROE of -0.05%. Regarding short-term risk, ACU is less volatile compared to EPC. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check EPC's competition here
ACU vs HELE Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, HELE has a market cap of 656.6M. Regarding current trading prices, ACU is priced at $51.88, while HELE trades at $25.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas HELE's P/E ratio is 8.54. In terms of profitability, ACU's ROE is +0.08%, compared to HELE's ROE of -0.48%. Regarding short-term risk, ACU is less volatile compared to HELE. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check HELE's competition here
ACU vs USNA Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, USNA has a market cap of 410.2M. Regarding current trading prices, ACU is priced at $51.88, while USNA trades at $20.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas USNA's P/E ratio is 12.34. In terms of profitability, ACU's ROE is +0.08%, compared to USNA's ROE of +0.02%. Regarding short-term risk, ACU is more volatile compared to USNA. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check USNA's competition here
ACU vs YSG Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, YSG has a market cap of 325.8M. Regarding current trading prices, ACU is priced at $51.88, while YSG trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas YSG's P/E ratio is -27.19. In terms of profitability, ACU's ROE is +0.08%, compared to YSG's ROE of -0.05%. Regarding short-term risk, ACU is more volatile compared to YSG. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check YSG's competition here
ACU vs EWCZ Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, ACU is priced at $51.88, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, ACU's ROE is +0.08%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, ACU is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check EWCZ's competition here
ACU vs NUS Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, NUS has a market cap of 254.9M. Regarding current trading prices, ACU is priced at $51.88, while NUS trades at $5.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas NUS's P/E ratio is 4.38. In terms of profitability, ACU's ROE is +0.08%, compared to NUS's ROE of +0.07%. Regarding short-term risk, ACU is more volatile compared to NUS. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check NUS's competition here
ACU vs WALD Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, WALD has a market cap of 209.3M. Regarding current trading prices, ACU is priced at $51.88, while WALD trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas WALD's P/E ratio is -2.95. In terms of profitability, ACU's ROE is +0.08%, compared to WALD's ROE of -0.48%. Regarding short-term risk, ACU is more volatile compared to WALD. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check WALD's competition here
ACU vs PTNM Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, ACU is priced at $51.88, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas PTNM's P/E ratio is 346.33. In terms of profitability, ACU's ROE is +0.08%, compared to PTNM's ROE of -0.99%. Regarding short-term risk, ACU is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check PTNM's competition here
ACU vs SKIN Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, SKIN has a market cap of 97.8M. Regarding current trading prices, ACU is priced at $51.88, while SKIN trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas SKIN's P/E ratio is -4.44. In terms of profitability, ACU's ROE is +0.08%, compared to SKIN's ROE of -0.09%. Regarding short-term risk, ACU is more volatile compared to SKIN. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SKIN's competition here
ACU vs UPXI Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, UPXI has a market cap of 63.3M. Regarding current trading prices, ACU is priced at $51.88, while UPXI trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas UPXI's P/E ratio is -0.19. In terms of profitability, ACU's ROE is +0.08%, compared to UPXI's ROE of -3.07%. Regarding short-term risk, ACU is more volatile compared to UPXI. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check UPXI's competition here
ACU vs SLSN Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, SLSN has a market cap of 60.2M. Regarding current trading prices, ACU is priced at $51.88, while SLSN trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas SLSN's P/E ratio is 69.31. In terms of profitability, ACU's ROE is +0.08%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, ACU is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check SLSN's competition here
ACU vs GROV Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, GROV has a market cap of 45.8M. Regarding current trading prices, ACU is priced at $51.88, while GROV trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas GROV's P/E ratio is -4.19. In terms of profitability, ACU's ROE is +0.08%, compared to GROV's ROE of -1.06%. Regarding short-term risk, ACU is more volatile compared to GROV. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check GROV's competition here
ACU vs AXIL Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, AXIL has a market cap of 37M. Regarding current trading prices, ACU is priced at $51.88, while AXIL trades at $5.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas AXIL's P/E ratio is 45.17. In terms of profitability, ACU's ROE is +0.08%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, ACU is less volatile compared to AXIL. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check AXIL's competition here
ACU vs UG Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, UG has a market cap of 36.5M. Regarding current trading prices, ACU is priced at $51.88, while UG trades at $8.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas UG's P/E ratio is 15.29. In terms of profitability, ACU's ROE is +0.08%, compared to UG's ROE of +0.21%. Regarding short-term risk, ACU is more volatile compared to UG. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check UG's competition here
ACU vs DSY Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, DSY has a market cap of 14.6M. Regarding current trading prices, ACU is priced at $51.88, while DSY trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas DSY's P/E ratio is -0.34. In terms of profitability, ACU's ROE is +0.08%, compared to DSY's ROE of +14.77%. Regarding short-term risk, ACU is less volatile compared to DSY. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check DSY's competition here
ACU vs PHH Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, ACU is priced at $51.88, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas PHH's P/E ratio is -0.53. In terms of profitability, ACU's ROE is +0.08%, compared to PHH's ROE of +0.38%. Regarding short-term risk, ACU is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check PHH's competition here
ACU vs BRSH Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, ACU is priced at $51.88, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas BRSH's P/E ratio is -0.01. In terms of profitability, ACU's ROE is +0.08%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, ACU is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check BRSH's competition here
ACU vs MTEX Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, MTEX has a market cap of 8.5M. Regarding current trading prices, ACU is priced at $51.88, while MTEX trades at $4.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas MTEX's P/E ratio is -0.66. In terms of profitability, ACU's ROE is +0.08%, compared to MTEX's ROE of -23.83%. Regarding short-term risk, ACU is less volatile compared to MTEX. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check MTEX's competition here
ACU vs TANH Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, TANH has a market cap of 2.9M. Regarding current trading prices, ACU is priced at $51.88, while TANH trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas TANH's P/E ratio is 0.05. In terms of profitability, ACU's ROE is +0.08%, compared to TANH's ROE of -0.25%. Regarding short-term risk, ACU is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check TANH's competition here
ACU vs BYAH Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, BYAH has a market cap of 291.3K. Regarding current trading prices, ACU is priced at $51.88, while BYAH trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas BYAH's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.08%, compared to BYAH's ROE of -6.53%. Regarding short-term risk, ACU is less volatile compared to BYAH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check BYAH's competition here
ACU vs BRSHW Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, ACU is priced at $51.88, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas BRSHW's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.08%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, ACU is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check BRSHW's competition here
ACU vs GROV-WT Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, ACU is priced at $51.88, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.08%, compared to GROV-WT's ROE of -1.06%. Regarding short-term risk, ACU is more volatile compared to GROV-WT. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check GROV-WT's competition here
ACU vs SUMR Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, ACU is priced at $51.88, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas SUMR's P/E ratio is -3.66. In terms of profitability, ACU's ROE is +0.08%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, ACU is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SUMR's competition here
ACU vs RDEN Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, ACU is priced at $51.88, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas RDEN's P/E ratio is -5.68. In terms of profitability, ACU's ROE is +0.08%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, ACU is more volatile compared to RDEN. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check RDEN's competition here
ACU vs REV Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 174.9M. In comparison, REV has a market cap of 0. Regarding current trading prices, ACU is priced at $51.88, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.78, whereas REV's P/E ratio is -1.19. In terms of profitability, ACU's ROE is +0.08%, compared to REV's ROE of +0.89%. Regarding short-term risk, ACU is more volatile compared to REV. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check REV's competition here